查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1848535

醫療設備契約製造市場按產品類型、服務類型、製程類型、材料類型和最終用途分類－2025年至2032年全球預測

Medical Device Outsourced Manufacturing Market by Product Type, Service Type, Process Type, Material Type, End Use - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療設備契約製造市場將成長至 821.3 億美元，複合年成長率為 11.30%。

關鍵市場統計數據
基準年 2024 348.7億美元
預計年份：2025年 388.6億美元
預測年份 2032 821.3億美元
複合年成長率 (%) 11.30%

醫療設備製造外包策略演進框架及其對創新路徑和供應鏈韌性的決定性影響

醫療設備的製造外包正從一種成本驅動型策略轉變為一種策略能力，這種能力塑造著創新流程、監管結果以及全球供應鏈的韌性。製造商不僅擴大將生產活動，還將複雜的工程設計、監管支援和端到端的供應鏈物流給專業合作夥伴。這種轉變源於醫療設備製造商專注於核心競爭力，例如臨床開發和市場推廣策略，同時依賴外部供應商來獲得規模、流程專業知識和合規基礎設施。

因此，契約製造製造商和服務供應商正在擴展其技術組合，涵蓋先進材料、積層製造和整合滅菌製程。這些供應商正在投資數位雙胞胎、流程分析和驗證框架，以滿足更嚴格的品質要求，並加快先進植入和診斷系統的上市速度。因此，採購和產品團隊必須應對更複雜的供應商生態系統，其中技術能力、監管記錄和地理覆蓋範圍都同等重要。

本執行摘要概述了當今醫療設備製造外包的營運動態、監管阻力和商業機會。它重點闡述了重塑夥伴關係的變革力量，分析了新貿易壁壘的累積影響，並將市場區隔和地理影響轉化為可供業務決策者和負責採購、品質和產品開發的職能領導者參考的戰術性建議。

技術創新、日益嚴格的監管和永續性壓力如何重塑醫療設備製造領域的外包夥伴關係和供應商競爭力

過去幾年，技術、監管和市場力量的共同作用從根本上改變了醫療設備原始設備製造商 (OEM) 的委託製造方式。積層製造和精密數控加工技術的進步拓展了可外包產品的範圍，實現了複雜幾何形狀、患者客製化植入以及更短的原型製作週期。同時，滅菌技術和物流能力的成熟，使得全球分散生產高品質產品成為可能。

監管機構對組合產品和數位健康設備的監管期望正朝著更嚴格的流程控制、更嚴格的供應商監管以及更完善的文件編制方向發展。因此，受託製造製造商正在將監管方面的專業知識融入他們的服務中，以確保新產品過渡期間技術文件和驗證包的順利轉移。同時，永續性和循環經濟的概念正在加速生產營運中材料替代和廢棄物最小化實踐的實施。

競爭格局正在不斷演變，專業供應商憑藉其在可製造性設計支援、可擴展的大批量生產和端到端物流的綜合能力，贏得了長期夥伴關係。同時，醫療器材製造商正在採用混合採購模式，將策略性長期合約與靈活的、針對特定項目的供應商相結合，以實現快速的創新週期。總而言之，這些轉變正在為外包關係建立新的基準，使那些能夠在產品開發、滅菌、法規支援和上市後監測等方面展現綜合能力的合作夥伴更受青睞。

評估不斷變化的美國關稅措施對跨境採購、供應商資格認證和本地生產策略的營運和策略影響

近期海關制度的調整以及影響零件進口和成品的新關稅的訂定，為依賴跨境供應鏈的製造商帶來了額外的複雜性。海關制度的變化迫使採購團隊重新評估供應商選擇標準，權衡貨物的總到岸成本、前置作業時間可靠性以及合規負擔。因此，企業正在調整籌資策略策略，以控制海關風險，同時保持與關鍵市場和臨床試驗地點的接近性。

為因應不斷變化的貿易政策，內部相關人員正在評估近岸外包或雙重採購策略，以降低對單一供應商的依賴並減輕關稅波動的影響。此類策略通常需要投資於合格的替代供應商、轉移製程知識以及更新供應商審核通訊協定。此外，一些公司正在加快向區域製造合作夥伴進行技術轉讓，以避免連續產品被重複徵收關稅，並更好地控制庫存和分銷。

這些貿易措施的整體效果是促使各方重新關注供應鏈圖譜繪製、情境規劃和合約彈性。跨職能團隊正優先考慮統一產品規格和模組化零件設計，以簡化供應商過渡。此外，法律和商務負責人正在將關稅觸發的重新定價條款和更長的技術轉移前置作業時間納入主服務協議，以保護淨利率並確保患者照護服務的連續性。

全面的細分洞察，揭示產品類型、服務產品、製造流程、材料選擇和最終用途背景如何影響供應商選擇和營運風險。

有效的細分分析需要清楚了解產品系列、服務範圍、製程能力、材料選擇和最終用途環境如何相互作用，從而確定外包的適用性和供應商的兼容性。產品類型的差異會影響監管路徑和污染控制要求。例如，植入和整形外科植入等醫療器械比許多牙科和外科器械需要更嚴格的冶金控制和認證。導管和管道需要考慮流體動態和生物相容性，並與滅菌方式的選擇密切相關。診斷設備則著重於電子元件和感測器的整合。

不同的服務類型決定了外包關係中價值的實現方式。提供設計和開發服務（包括概念開發和工程分析）的供應商可以透過及早解決可製造性和驗證問題來降低生產轉移風險。涵蓋初級和二級包裝的組裝和包裝服務能夠提高下游環節的效率，例如標籤、序列化和低溫運輸要求。物流能力（例如低溫運輸和一般物流）對於溫度敏感型診斷至關重要，而滅菌方式（例如電子束、環氧乙烷和伽馬射線輻照）必須符合材料相容性和監管核准。從過渡製造和快速原型製作到大規模生產，不同的物流模式需要不同的品質系統和資本結構。

製程類型的選擇對前置作業時間、成本結構和設計自由度有顯著影響。積層製造方法，包括電子束熔化、熔融沉積建模、選擇性雷射燒結和光固化成形法，能夠製造病患客製化的醫療器材和連網組件，但需要完善的後處理和可追溯性。而射出成型、吹塑成型、擠出成型和數控加工等傳統工藝，對於公差和表面光潔度要求極高的聚合物和金屬零件的大批量生產仍然至關重要。

材料類型的選擇決定了供應商的產能需求和風險管理優先順序。電路基板和感測器等電子元件需要供應鏈的連續性和過時管理，而鋁、不銹鋼和鈦等金屬的加工和腐蝕特性各不相同。聚碳酸酯、聚乙烯、聚丙烯和聚氯乙烯等塑膠必須評估其生物相容性和耐滅菌性。無論是高黏度矽酮或液態矽酮，矽酮配方都具有柔軟的觸感和良好的密封性能，但需要專業的成型和固化技術。

醫院和專科中心要求設備和植入在嚴格的臨床工作流程下具備可靠性；門診醫療中心和診所通常優先考慮緊湊易用的系統；而居家醫療場景則需要耐用、易用且消毒和維護流程簡化的產品。將這些細分維度整合到供應商選擇框架中，可以幫助設備製造商將技術要求與營運能力、監管歷史和地理覆蓋範圍相匹配，從而最佳化開發成本和生命週期成本。

關鍵區域的區域動態和供應鏈因素會影響製造策略、合規應對措施和供應商產能部署。

區域動態是籌資策略的核心，因為區域監管預期、人事費用和物流基礎設施直接影響供應商的能力和產品上市時間。在美洲，毗鄰主要臨床中心和成熟的監管路徑有利於高複雜度設備的快速迭代，並促進與擁有成熟驗證經驗的契約製造製造商建立深度夥伴關係。同時，對關鍵電子元件可靠供應的需求正在推動區域化策略的發展，以減少對漫長遠洋運輸和海關不確定性的影響。

歐洲、中東和非洲的監管環境日益趨於統一，但市場進入卻依然分散。歐洲部分地區擁有大量技術人才和先進材料供應商，推動植入式醫療設備和精密儀器的創新，但製造商仍需應對各國法規和標籤要求的差異。此外，該地區物流複雜，因此需要採用多式聯運方案，並利用區域品質中心集中管理無菌儲存和最終組裝。

亞太地區仍然是大規模製造、先進聚合物加工和快速成長的零件供應商的中心。不斷成長的國內需求和不斷擴大的臨床基礎設施正推動亞太地區的製造商向價值鏈高階發展，提供大規模生產和專業加工服務，例如高精度射出成型和積層製造服務。儘管如此，瞄準亞太市場的公司必須投資於供應商發展，以應對各種法律規範，並確保文件記錄的一致性、可追溯性和合規性。

公司對競爭格局和自身能力的洞察凸顯了整合服務組合、細分市場專業化和產業整合如何重新定義供應商差異化。

領先的契約製造製造商和服務供應商正從多個方面實現差異化：整合面向製造的設計、滅菌和物流等一體化服務組合；投資於數位化品質體系，實現即時過程監控和審核；以及建構積層製造和先進材料方面的專項能力。市場領導正在實施標準化的驗證手冊和跨站點認證通訊協定，以減少跨國生產的摩擦，並隨著需求的變化加速產能擴張。

同時，一些中型專業供應商正透過專注於特定產品類型和技術而獲得市場認可，例如用於整形外科植入的高精度鈦加工或用於診斷外殼的先進聚合物包覆成型。這些專業供應商在研發階段通常具有更高的靈活性，能夠快速原型製作並進行迭代設計調整，而這是規模更大、以大規模生產為導向的供應商難以企及的。醫療器材創新者與這些專業供應商之間的策略夥伴關係通常包括共同投資醫療器材認證和聯合提交監管文件，以簡化商業化流程。

投資者和企業支持的供應商正透過整合和跨國擴張重塑供應商格局，將集中化的合規職能和標準化的營運流程引入新收購的地區。這一趨勢提高了跨國製造商的一致性，但也帶來了與文化、IT系統和品質指標協調相關的整合風險。最終，成功的公司需要在技術深度、監管能力和商業靈活性之間取得平衡，以滿足OEM廠商在產品生命週期中不斷變化的需求。

為經營團隊提供可操作的建議，以透過調整供應商策略、加強技術轉移實踐和加快數位化可追溯性來降低風險並保持創新。

高階主管應優先考慮策略性供應商細分，將核心產品與擁有監管經驗和材料專業知識的合作夥伴相匹配。對於複雜的植入和診斷系統，應要求供應商提供驗證活動、滅菌相容性和上市後監測支援的綜合證據。同時，對於早期項目，應採用靈活的供應商體系，因為在這些階段，快速原型製作和迭代設計變更比規模效益更為重要。這種雙管齊下的方法既能保持創新步伐，又能保障商業供應的可靠性。

在營運層面，企業應投資完善技術轉移流程手冊，明確文件標準、驗收標準與升級通訊協定。整合研發、品質、採購和監管團隊，可確保跨部門協作、順利交接，並為所有相關人員提供一套統一的成功指標。此外，還應建立合約機制，以應對關稅波動、材料替代和產能擴張里程碑等問題，從而在不抑制供應商投資的前提下，共用商業性保障。

最後，領導者應加快數位化舉措，提升多層供應鏈的透明度。實施端到端可追溯性系統，與關鍵供應商採用相容的製造執行系統，並使用數據驅動的主導評分卡，綜合考量準時交付、品質表現和應對力變化的能力。這些措施有助於在供應鏈中斷時快速進行根本原因分析，並支援持續改進計劃，從而提升產品品質和成本可預測性。

採用穩健的混合方法研究途徑，結合相關人員訪談、標準調查和三角驗證，以檢驗供應商能力和供應鏈動態。

本摘要的分析是基於對設備製造商和服務供應商的高級採購、品質和工程負責人進行的訪談，以及與監管和物流專家的專題討論。這些定性資訊與已發布的監管指南、技術白皮書和公司揭露資訊進行交叉比對，以檢驗能力聲明並梳理反覆出現的營運挑戰。訪談通訊協定主要圍繞著供應商選擇標準、技術轉移經驗、滅菌策略以及對近期貿易政策變化的因應措施。

二次研究包括對植入、診斷設備和一次性耗材等醫療器材相關的技術標準、滅菌驗證方法和製程控制框架進行系統性回顧。在適用情況下，我們將已記錄的審核結果與監管機構的檢查趨勢進行比較，以評估供應商群體的成熟度。調查方法強調可重複性，為此我們制定了訪談指南、資料來源記錄以及檢驗循環機制，將調查結果草稿與專家共用，以獲得回饋並進行完善。

快速發展的技術和企業層面的策略轉變可能會改變不同研發週期之間的能力格局。為了因應這個問題，我們的研究在評估新興技術時採用了較保守的解釋閾值，並納入了基於情境的敏感性檢驗，以考慮供應商績效和地緣政治環境的變化。

結論：我們強調了基於能力的外包、具有韌性的採購策略和數位透明度對於持續設備創新的策略必要性。

對於尋求在創新敏捷性、法規遵循和成本控制之間取得平衡的醫療設備公司而言，製造外包已成為一項至關重要的策略槓桿。先進的製造流程、不斷發展的滅菌方案以及細緻入微的材料選擇之間的相互作用，要求原始設備製造商 (OEM) 以投資組合的視角來處理供應商關係，將供應商的優勢與產品的複雜性和生命週期階段相匹配。監管和貿易環境增加了營運風險，而這些風險可以透過積極主動的風險評估、多元化的採購管道以及合約保障措施來降低。

展望未來，競爭優勢將屬於那些能夠將嚴格的供應商資質認證、靈活的合約簽訂以及對數位化系統（可即時監控生產和品質指標）的投資相結合的企業。醫療設備製造商若將外包視為一種能力而非單純的成本削減手段，便能加速創新，透過更高品質的產品改善病患療效，並建構更具韌性的供應鏈網路，從而抵禦政策和市場衝擊。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 積層製造在客製化醫療植入和器械領域的應用日益廣泛
  • 擴大設備原始設備製造商 (OEM) 和合約研發生產機構 (CDMO) 之間的夥伴關係模式，以加快監管核准流程。
  • 在精密組裝的契約製造工廠中，先進機器人和自動化技術的整合度不斷提高
  • 透過近岸外包和擴大區域製造地來緩解醫療設備供應鏈中斷問題
  • 實施連續製造程序，以提高設備生產的產量和品質一致性
  • 注射劑和生物製劑市場的成長推動了對無菌合約灌裝包裝服務的需求激增。
  • 外包製造互聯醫療設備領域對網路安全和資料完整性合規性的關注度日益提高，這體現在各個方面。
  • 在CDMO中實施人工智慧驅動的流程分析數位雙胞胎，以最佳化生產效率並降低成本
  • 醫療設備外包業務應注重永續製造方法和環保材料
  • 全球公司策略性地整合了一家小型、專業化的首席行銷長（CMO），以擴展服務組合和能力。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章醫療設備契約製造市場（依產品類型分類）

  • 心臟病學器械
  • 導管和管子
  • 牙科設備
  • 診斷設備
  • 整形外科植入
  • 手術器械

第9章醫療設備契約製造市場（按服務類型分類）

  • 組裝和包裝
    • 初級包裝
    • 二級包裝
  • 設計與開發
    • 概念開發
    • 工程分析
  • 物流
    • 低溫運輸
    • 一般物流
  • 製造業
    • 客製化生產
    • 大規模生產
  • 原型製作
    • 橋樑製造
    • 快速原型製作
  • 消毒
    • 電子束
    • 環氧乙烷
    • 伽瑪射線照射

第10章醫療設備契約製造市場（依工藝類型分類）

  • 積層製造
    • 電子束熔化
    • 熔融沈積成型
    • 選擇性雷射燒結
    • 立體光固成型
  • 吹塑成型
  • CNC加工
  • 擠壓
  • 射出成型

第11章 按材料類型分類的醫療設備契約製造市場

  • 電子元件
    • 電路基板
    • 感應器
  • 金屬
    • 鋁
    • 不銹鋼
    • 鈦
  • 塑膠
    • 聚碳酸酯
    • 聚乙烯
    • 聚丙烯
    • PVC
  • 矽酮
    • 高黏度矽油
    • 液態矽油

第12章醫療設備契約製造市場（依最終用途分類）

  • 門診治療中心
  • 診所
  • 家庭醫療保健
  • 醫院
  • 專業中心

第13章醫療設備契約製造市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章醫療設備契約製造市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫療設備契約製造市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Jabil Inc.
    • Flex Ltd.
    • Sanmina Corporation
    • Celestica Inc.
    • Plexus Corp.
    • Benchmark Electronics, Inc.
    • TT Electronics plc
    • Kimball Electronics, Inc.
    • Integer Holdings Corporation
    • SMTC Corporation
Product Code: MRR-FD3F12D53CF4

The Medical Device Outsourced Manufacturing Market is projected to grow by USD 82.13 billion at a CAGR of 11.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 34.87 billion
Estimated Year [2025] USD 38.86 billion
Forecast Year [2032] USD 82.13 billion
CAGR (%) 11.30%

Framing the strategic evolution of outsourced manufacturing in medical devices and its decisive influence on innovation pathways and supply chain resilience

Outsourced manufacturing for medical devices has transitioned from a cost-driven tactic to a strategic capability that shapes innovation pipelines, regulatory outcomes, and the resilience of global supply chains. Manufacturers increasingly transfer not only production activities but also complex engineering, regulatory support, and end-to-end supply logistics to specialist partners. This shift is driven by device makers' focus on core competencies-such as clinical development and go-to-market strategy-while relying on external providers for scale, process expertise, and compliance infrastructure.

Consequently, contract manufacturers and service providers are expanding their technical portfolios to include advanced materials, additive manufacturing, and integrated sterilization processes. These providers are investing in digital twins, process analytics, and validation frameworks to meet stricter quality expectations and to reduce time-to-market for sophisticated implantables and diagnostic systems. As a result, procurement and product teams must navigate a more complex supplier ecosystem where technical capability, regulatory track record, and geographic footprint are equally important considerations.

This executive summary synthesizes the operational dynamics, regulatory headwinds, and commercial opportunities that characterize outsourced manufacturing for medical devices today. It highlights the transformative forces reshaping partnerships, analyzes the cumulative effects of new trade barriers, and translates segmentation- and region-level implications into tactical recommendations for executive decision-makers and functional leaders responsible for sourcing, quality, and product development.

How technological innovation, regulatory tightening, and sustainability pressures are reshaping outsourcing partnerships and supplier competitiveness in medical device manufacturing

The last several years have seen a confluence of technological, regulatory, and market forces that are fundamentally altering how device OEMs approach outsourced manufacturing. Advances in additive manufacturing and precision CNC machining have expanded the set of products that are viable for outsourcing, enabling complex geometries, patient-specific implants, and faster prototyping cycles. Meanwhile, sterilization technologies and logistics capabilities have matured to support globally distributed production with consistent quality outcomes.

Regulatory expectations have shifted toward tighter process control, more rigorous supplier oversight, and enhanced documentation for combination products and digital health-enabled devices. Consequently, contract manufacturers are integrating regulatory affairs expertise into their service offerings, enabling a smoother transfer of technical documentation and validation packages during new product transitions. At the same time, sustainability imperatives and circularity considerations are accelerating material substitution and waste-minimization practices within manufacturing operations.

From a commercial perspective, the competitive landscape is evolving: specialized providers that combine design-for-manufacturability support, scalable volume manufacturing, and end-to-end logistics are winning longer-term partnerships. In parallel, device makers are adopting hybrid sourcing models that blend strategic long-term agreements with agile, program-specific suppliers for rapid innovation cycles. Collectively, these shifts favor partners that can demonstrate integrated capabilities across product development, sterilization, regulatory support, and post-market surveillance, creating a new baseline for outsourcing relationships.

Assessing the operational and strategic consequences of evolving United States tariff measures on cross-border sourcing, supplier qualification, and regional production strategies

Recent adjustments to tariff regimes and the introduction of new duties affecting component imports and finished goods have introduced additional complexity for manufacturers dependent on cross-border supply chains. Tariff changes have prompted procurement teams to reevaluate supplier selection criteria, weighing the total landed cost of goods against lead-time reliability and regulatory compliance burdens. As a result, businesses are recalibrating sourcing strategies to manage customs exposure while preserving proximity to key markets and clinical study sites.

In response to trade policy shifts, internal stakeholders are assessing nearshoring and dual-sourcing strategies to mitigate single-source dependencies and to reduce the impact of tariff volatility. These approaches often require investments in qualification of alternate suppliers, transfer of process knowledge, and updating of supplier audit protocols. Moreover, some companies are accelerating technology transfers to regional manufacturing partners to avoid repeated customs duties on successive product iterations and to maintain tighter control over inventory and distribution.

The aggregate effect of these trade actions is a renewed focus on supply chain mapping, scenario planning, and contractual flexibility. Cross-functional teams are prioritizing harmonized product specifications and modular component designs that simplify supplier transitions. In addition, legal and commercial negotiators are including tariff-triggered repricing clauses and longer lead times for technology transfer into master services agreements to protect margins and ensure continuity of patient care delivery.

Comprehensive segmentation insights showing how product categories, service offerings, manufacturing processes, material choices, and end-use contexts drive supplier selection and operational risk

Effective segmentation analysis requires a clear understanding of how product portfolios, service scopes, process capabilities, material selection, and end-use contexts interact to determine outsourcing suitability and supplier fit. Product Type differentiation influences regulatory pathways and contamination control requirements; devices such as cardiology implants and orthopedic implants demand tighter metallurgical controls and more exacting certification than many dental devices or surgical instruments. Catheters and tubing introduce fluid dynamics and biocompatibility considerations that intersect with sterilization choices, while diagnostic equipment places a premium on electronic components and sensor integration.

Service Type distinctions determine where value is realized in an outsourced relationship. Providers that offer design and development services, including concept development and engineering analysis, can de-risk manufacturing transfers by resolving manufacturability and validation issues early. Assembly and packaging services that encompass both primary and secondary packaging create downstream efficiencies in labeling, serialization, and cold chain requirements. Logistics capabilities such as cold chain and general logistics are pivotal for temperature-sensitive diagnostics, and sterilization options-spanning e-beam, ethylene oxide, and gamma irradiation-must align with material compatibility and regulatory acceptance. Manufacturing modalities that range from bridge manufacturing and rapid prototyping to volume production require different quality systems and capital structures.

Process Type choices materially shape lead times, cost structures, and design freedom. Additive manufacturing modalities including electron beam melting, fused deposition modeling, selective laser sintering, and stereolithography enable patient-specific devices and consolidated assemblies but necessitate robust post-processing and traceability. Traditional processes such as injection molding, blow molding, extrusion, and CNC machining remain essential for high-volume polymeric and metallic components where tolerances and surface finishes are critical.

Material Type selection drives supplier capability needs and risk management priorities. Electronic components such as circuit boards and sensors require supply chain continuity and obsolescence management, while metals like aluminum, stainless steel, and titanium present differing machining and corrosion profiles. Plastic families, including polycarbonate, polyethylene, polypropylene, and PVC, must be evaluated for biocompatibility and sterilization resilience. Silicone formulations, whether high consistency or liquid silicone, offer soft-touch interfaces and sealing properties but demand specific molding and curing expertise.

End Use context also affects outsourcing decisions: hospitals and specialty centers expect equipment and implant reliability under rigorous clinical workflows, ambulatory care centers and clinics often prioritize compact, easy-to-use systems, and home healthcare scenarios require durable, user-friendly designs with simplified sterilization and maintenance pathways. Integrating these segmentation dimensions into supplier selection frameworks enables device makers to match technical requirements with operational capabilities, regulatory history, and geographic presence to optimize both development and lifecycle costs.

Regional dynamics and supply chain considerations across major territories that affect manufacturing strategy, compliance readiness, and supplier capability deployment

Geographic dynamics are central to sourcing strategy because regional regulatory expectations, labor costs, and logistics infrastructure directly affect supplier capabilities and time-to-market. In the Americas, proximity to major clinical centers and established regulatory pathways supports rapid iterations for high-complexity devices and fosters deep partnerships with contract manufacturers that have proven validation experience. Meanwhile, the need for secure supply of critical electronic components is shaping localized strategies that reduce exposure to long ocean freight lanes and customs uncertainty.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some subregions coexists with fragmented market access in others. Strong engineering talent pools and advanced materials suppliers in parts of Europe drive innovation in implantable devices and precision instruments, but manufacturers must reconcile differing national regulations and labeling requirements. In addition, logistical complexity across this broader region encourages multi-modal distribution plans and the use of regional quality hubs to centralize sterile storage and final assembly.

Asia-Pacific continues to be a source of scale manufacturing, advanced polymer processing, and a rapidly growing base of component suppliers. Rising domestic demand and expanding clinical infrastructures are enabling regionally based manufacturers to move up the value chain, offering both volume manufacturing and specialized processing such as high-precision injection molding and additive manufacturing services. Nevertheless, companies targeting Asia-Pacific markets must navigate variable regulatory frameworks and invest in supplier development to ensure consistent documentation, traceability, and compliance.

Competitive and capability-focused company insights highlighting how integrated service portfolios, niche specialization, and consolidation are redefining supplier differentiation

Leading contract manufacturers and service providers are differentiating along several axes: integrated service portfolios that combine design-for-manufacturing with sterilization and logistics; investments in digital quality systems that enable real-time process monitoring and auditability; and targeted capability builds in additive manufacturing and advanced materials. Market leaders are deploying standardized validation playbooks and cross-site qualification protocols to reduce the friction of multi-country production and to accelerate capacity scaling when demand shifts.

At the same time, mid-tier niche providers are gaining traction by specializing in particular product categories or technical capabilities, such as high-precision titanium processing for orthopedic implants or advanced polymer overmolding for diagnostic housings. These focused providers often offer greater agility during development phases, enabling rapid prototyping and iterative design adjustments that larger, volume-oriented suppliers may find harder to accommodate. Strategic partnerships between device innovators and these niche suppliers frequently include co-investments in equipment qualification and joint regulatory submissions to streamline commercialization.

Investor-backed and corporate-backed providers are also reshaping the supplier landscape through consolidation and cross-border expansions, bringing centralized compliance functions and standardized operating procedures to newly acquired sites. This trend is improving consistency for multinational manufacturers but also introduces integration risks related to culture, IT systems, and harmonized quality metrics. Ultimately, successful companies balance technical depth, regulatory competence, and commercial flexibility to meet the evolving needs of OEMs across product life cycles.

Actionable recommendations for executive teams to align supplier strategy, fortify technology transfer practices, and accelerate digital traceability to mitigate risk and sustain innovation

Executives should prioritize strategic supplier segmentation that aligns core products with partners possessing demonstrable regulatory experience and material expertise. For complex implants and diagnostic systems, require suppliers to present consolidated evidence of validation activities, sterilization compatibility, and post-market surveillance support. At the same time, adopt an agile supplier roster for early-stage programs where rapid prototyping and iterative design changes are more valuable than scale efficiencies. This dual approach preserves innovation velocity while safeguarding commercial supply reliability.

Operationally, organizations should invest in strengthened technology transfer playbooks that codify documentation standards, acceptance criteria, and escalation protocols, thereby reducing cycle time during supplier transitions. Cross-functional readiness-bringing together R&D, quality, procurement, and regulatory teams-will create smoother handoffs and ensure that all stakeholders share a single set of success metrics. In addition, introduce contractual mechanisms that address tariff volatility, material substitution, and capacity ramp milestones to provide commercial protections without stifling supplier investment.

Finally, leaders should accelerate digitalization initiatives that improve transparency across multi-tier supply chains. Implement end-to-end traceability systems, adopt manufacturing execution systems compatible with key suppliers, and use data-driven supplier scorecards that combine on-time delivery, quality performance, and responsiveness to change. These steps enable faster root-cause analysis during disruptions and support continuous improvement programs that enhance both product quality and cost predictability.

Robust mixed-methods research approach combining stakeholder interviews, standards review, and triangulation to validate supplier capabilities and supply chain dynamics

The analysis underpinning this summary synthesizes primary interviews with senior procurement, quality, and engineering leaders at device manufacturers and service providers, coupled with targeted discussions with regulatory and logistics experts. These qualitative inputs were triangulated with publicly available regulatory guidance, technical white papers, and company disclosures to validate capability claims and to map recurring operational challenges. Interview protocols focused on supplier selection criteria, technology transfer experiences, sterilization strategies, and responses to recent trade policy shifts.

Secondary research included systematic review of technical standards, sterilization validation methodologies, and process control frameworks relevant to device types such as implants, diagnostic equipment, and disposable consumables. Where applicable, capabilities were cross-referenced against documented audit outcomes and regulatory inspection trends to assess maturity levels among supplier cohorts. The methodology emphasized reproducibility through documented interview guides, source logs, and a validation loop in which draft findings were shared with subject matter experts for feedback and refinement.

Limitations of the approach are inherent to any cross-industry synthesis: rapidly evolving technologies and company-level strategic changes can alter capability footprints between research cycles. To address this, the study applied conservative interpretation thresholds when evaluating nascent technologies and incorporated scenario-based sensitivity checks to account for variability in supplier performance and geopolitical conditions.

Concluding synthesis underscoring the strategic imperative of capability-aligned outsourcing, resilient sourcing strategies, and digital transparency for sustained device innovation

Outsourced manufacturing has become an indispensable strategic tool for medical device companies seeking to balance innovation agility with regulatory compliance and cost management. The interplay of advanced manufacturing processes, evolving sterilization options, and nuanced material selections requires that OEMs approach supplier relationships with a portfolio mindset-matching supplier strengths to product complexity and life-cycle stage. Regulatory and trade environments add layers of operational risk that can be mitigated through proactive mapping, diversified sourcing, and contractual safeguards.

Looking ahead, the competitive advantage will accrue to organizations that combine rigorous supplier qualification, agile contracting, and investment in digital systems that provide real-time visibility into production and quality metrics. By treating outsourcing as a capability rather than a mere cost lever, device companies can accelerate innovation, improve patient outcomes through higher-quality products, and create more resilient supply networks that withstand policy and market shocks.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of additive manufacturing techniques for customized medical implants and devices
  • 5.2. Growing partnership models between device OEMs and CDMOs to accelerate regulatory approval pathways
  • 5.3. Rising integration of advanced robotics and automation in contract manufacturing facilities for precision assembly
  • 5.4. Expansion of nearshoring and regional manufacturing hubs to mitigate supply chain disruptions for medical devices
  • 5.5. Implementation of continuous manufacturing processes to enhance throughput and quality consistency in device production
  • 5.6. Surge in demand for sterile contract fill finish services driven by growth in injectable and biologic medical products
  • 5.7. Heightened focus on cybersecurity and data integrity compliance in outsourced manufacturing of connected medical devices
  • 5.8. Adoption of AI driven process analytics and digital twins to optimize production efficiency and reduce costs in CDMOs
  • 5.9. Increasing emphasis on sustainable manufacturing practices and ecofriendly materials in medical device outsourcing
  • 5.10. Strategic consolidation of small specialized CMOs by global players to broaden service portfolios and capabilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Outsourced Manufacturing Market, by Product Type

  • 8.1. Cardiology Devices
  • 8.2. Catheters And Tubing
  • 8.3. Dental Devices
  • 8.4. Diagnostic Equipment
  • 8.5. Orthopedic Implants
  • 8.6. Surgical Instruments

9. Medical Device Outsourced Manufacturing Market, by Service Type

  • 9.1. Assembly & Packaging
    • 9.1.1. Primary Packaging
    • 9.1.2. Secondary Packaging
  • 9.2. Design & Development
    • 9.2.1. Concept Development
    • 9.2.2. Engineering Analysis
  • 9.3. Logistics
    • 9.3.1. Cold Chain
    • 9.3.2. General Logistics
  • 9.4. Manufacturing
    • 9.4.1. Custom Manufacturing
    • 9.4.2. Volume Manufacturing
  • 9.5. Prototyping
    • 9.5.1. Bridge Manufacturing
    • 9.5.2. Rapid Prototyping
  • 9.6. Sterilization
    • 9.6.1. E-Beam
    • 9.6.2. Ethylene Oxide
    • 9.6.3. Gamma Irradiation

10. Medical Device Outsourced Manufacturing Market, by Process Type

  • 10.1. Additive Manufacturing
    • 10.1.1. Electron Beam Melting
    • 10.1.2. Fused Deposition Modeling
    • 10.1.3. Selective Laser Sintering
    • 10.1.4. Stereolithography
  • 10.2. Blow Molding
  • 10.3. CNC Machining
  • 10.4. Extrusion
  • 10.5. Injection Molding

11. Medical Device Outsourced Manufacturing Market, by Material Type

  • 11.1. Electronic Components
    • 11.1.1. Circuit Boards
    • 11.1.2. Sensors
  • 11.2. Metal
    • 11.2.1. Aluminum
    • 11.2.2. Stainless Steel
    • 11.2.3. Titanium
  • 11.3. Plastic
    • 11.3.1. Polycarbonate
    • 11.3.2. Polyethylene
    • 11.3.3. Polypropylene
    • 11.3.4. PVC
  • 11.4. Silicone
    • 11.4.1. High Consistency Silicone
    • 11.4.2. Liquid Silicone

12. Medical Device Outsourced Manufacturing Market, by End Use

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Home Healthcare
  • 12.4. Hospitals
  • 12.5. Specialty Centers

13. Medical Device Outsourced Manufacturing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Device Outsourced Manufacturing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Device Outsourced Manufacturing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Jabil Inc.
    • 16.3.2. Flex Ltd.
    • 16.3.3. Sanmina Corporation
    • 16.3.4. Celestica Inc.
    • 16.3.5. Plexus Corp.
    • 16.3.6. Benchmark Electronics, Inc.
    • 16.3.7. TT Electronics plc
    • 16.3.8. Kimball Electronics, Inc.
    • 16.3.9. Integer Holdings Corporation
    • 16.3.10. SMTC Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CARDIOLOGY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CATHETERS AND TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DENTAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ASSEMBLY & PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PRIMARY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CONCEPT DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ENGINEERING ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY COLD CHAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GENERAL LOGISTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CUSTOM MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY VOLUME MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROTOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BRIDGE MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY RAPID PROTOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY E-BEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRON BEAM MELTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY FUSED DEPOSITION MODELING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SELECTIVE LASER SINTERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CNC MACHINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ELECTRONIC COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY CIRCUIT BOARDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL DEVICE OUTSOURCED MANUFACTURING MARKET SIZE,